Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adherence and Persistence to Biological Drugs for Psoriasis: Systematic Review with Meta-Analysis
Eugenia Piragine, Davide Petri, Alma Martelli, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 6, pp. 1506-1506
Open Access | Times Cited: 25

Showing 25 citing articles:

Adherence to Oral Antidiabetic Drugs in Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis
Eugenia Piragine, Davide Petri, Alma Martelli, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1981-1981
Open Access | Times Cited: 28
Biologic Treatment Adherence and Persistence in Patients with Palmoplantar Pustulosis: A Real-World, Claims-Based Study
Steven R. Feldman, Ran Gao, Rhonda L. Bohn, et al.
Advances in Therapy (2025)
Open Access
[Translated article] Persistence: The current state of the art
Misael Rodriguez Goicoechea, E Tejedor Tejada, Joaquín Borrás Blasco
Farmacia Hospitalaria (2024) Vol. 48, Iss. 3, pp. T141-T141
Open Access | Times Cited: 4
Association of Obesity and Innate Immune Markers With Resistance to Biologic Therapy in Psoriasis
Hee Joo Kim, Eun Hui Lee, YunJae Jung
JAMA Dermatology (2025)
Closed Access
Therapeutic Strategies and Decision‐Making to Optimize Psoriasis Treatment: A French National Survey Based on Virtual Case Vignettes
N. Quiles‐Tsimaratos, N. Jouan, A. Vermersch‐Langlin, et al.
Dermatologic Therapy (2025) Vol. 2025, Iss. 1
Open Access
On the horizon; considerations on convenience of oral biologic agents in psoriasis
Seán O’Malley, Clióna Feighery
International Journal of Pharmacy Practice (2025)
Closed Access
Poor adherence to and persistence with biologics in generalized pustular psoriasis: A claim-based study using real-world data from two large US databases
Steven R. Feldman, Rhonda L. Bohn, Ran Gao, et al.
JAAD International (2024) Vol. 15, pp. 78-83
Open Access | Times Cited: 2
Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan
Yayoi Tada, Ahmed M. Soliman, Kanako Ishii, et al.
Dermatology and Therapy (2023) Vol. 14, Iss. 1, pp. 99-114
Open Access | Times Cited: 6
Psoriasis/Psoriatic Arthritis Patients’ Long-term Treatment Patterns and Adherence to Systemic Treatments Monitoring Recommendations
Åsa Krantz, Juan Jesús Carrero, Yuanhang Yang, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv6505-adv6505
Open Access | Times Cited: 5
Tildrakizumab for moderate-to-severe plaque psoriasis in Chinese patients: A 12-week randomized placebo-controlled phase III trial with long-term extension
Yu Chen, Songmei Geng, Bin Yang, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 10, pp. 1190-1198
Open Access | Times Cited: 1
Gene expression profile of mitogen-activated kinases and microRNAs controlling their expression in HaCaT cell culture treated with lipopolysaccharide A and cyclosporine A
Michał Wójcik, Nikola Zmarzły, Alicja Derkacz, et al.
Cell Cycle (2024) Vol. 23, Iss. 3, pp. 279-293
Open Access | Times Cited: 1
Expression profile of mRNAs and miRNAs related to mitogen-activated kinases in HaCaT cell culture treated with lipopolysaccharide a and adalimumab
Michał Wójcik, Aleksandra Plata-Babula, Amelia Głowaczewska, et al.
Cell Cycle (2024) Vol. 23, Iss. 4, pp. 385-404
Open Access | Times Cited: 1
Adherence, persistence and treatment switching in psoriasis
Fiorenzo Santoleri, Felice Musicco, Chiara Fulgenzio, et al.
Immunotherapy (2024) Vol. 16, Iss. 9, pp. 611-621
Closed Access | Times Cited: 1
[Translated article] Perceived quality of life in patients with psoriasis treated with interleukin 17 or 23 inhibitors
Bárbara Anguita-Montenegro, Vera Lucía Areas-del Águila, Elena Palacios-Moya, et al.
Farmacia Hospitalaria (2024) Vol. 48, Iss. 5, pp. T204-T211
Open Access | Times Cited: 1
IL-17 and -23 Inhibitors for the Treatment of Psoriasis
Sonali Batta, Ramlah Khan, Marcus Zaayman, et al.
EMJ Allergy & Immunology (2023)
Open Access | Times Cited: 3
Discontinuation of biologic therapy in patients with rheumatoid arthritis and ankylosing spondylitis: analysis from multicenter cohort study
N. El Ouardi, A. El Maghraoui, H.J. Djossou, et al.
Rheumatology International (2022) Vol. 43, Iss. 1, pp. 79-87
Closed Access | Times Cited: 3
Calidad de vida percibida por los pacientes con psoriasis tratados con inhibidores de interleucina 17 y 23
Bárbara Anguita-Montenegro, Vera Lucía Areas-del Águila, Elena Palacios-Moya, et al.
Farmacia Hospitalaria (2024) Vol. 48, Iss. 5, pp. 204-211
Open Access
Adherence to Psoriasis Therapies
Kawaiola C. Aoki, Summer Wong, Jessica Q. Duong, et al.
Dermatologic Clinics (2024) Vol. 42, Iss. 3, pp. 495-506
Closed Access
A single-center, retrospective study of treatment adherence for biological treatment in patients with psoriasis
Chul Jong Park, Joo ho Jeong, Kyung Ho Lee, et al.
Daehan geonseon hakoeji (Online) (2024) Vol. 21, Iss. 1, pp. 19-25
Open Access
Revealing patient characteristics and treatment outcomes in ultra-long biologic users for psoriasis
Nikki F T Henckens, M.E. Otero, J. M. P. A. van den Reek, et al.
Clinical and Experimental Dermatology (2024)
Open Access
Real‐World Experience of Secukinumab Treatment in Patients with Moderate‐to‐Severe Plaque Psoriasis in Greece: 3‐Year Interim Results of the SERENA Study
D. Ioannides, Dimitrios Rigopoulos, Markos Papakonstantis, et al.
Dermatologic Therapy (2024) Vol. 2024, Iss. 1
Open Access
Factors Affecting Treatment Persistence in Japanese Patients with Psoriasis Prescribed Biologics: A Real-World Study Using an Insurance Claim Database
Celine Miyazaki, Junya Masuda, Phiona I-Ching Tsai, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 11, pp. 2999-3015
Open Access
Healthcare Provider Administration of Biologics for Patients with Plaque Psoriasis: Literature Review and Clinical Considerations.
Matthew Brunner, Keri Holyoak, Douglas DiRuggiero
PubMed (2023) Vol. 16, Iss. 12 Suppl 2, pp. S20-S25
Closed Access | Times Cited: 1
Use of Biological Drugs for Psoriasis: A Drug-Utilization Study Using Tuscan Administrative Databanks
Sabrina Giometto, Silvia Tillati, Laura Baglietto, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 11, pp. 6799-6799
Open Access | Times Cited: 2
Persistencia, estado del arte
Misael Rodríguez Goicoechea, E Tejedor Tejada, Joaquín Borrás Blasco
Farmacia Hospitalaria (2023) Vol. 48, Iss. 3, pp. 141-141
Open Access
Page 1

Scroll to top